Published in Infect Immun on December 01, 2001
Decline of placental malaria in southern Ghana after the implementation of intermittent preventive treatment in pregnancy. Malar J (2007) 1.66
Antibodies to variant surface antigens of Plasmodium falciparum-infected erythrocytes and adhesion inhibitory antibodies are associated with placental malaria and have overlapping and distinct targets. J Infect Dis (2004) 1.63
The structure of a chondroitin sulfate-binding domain important in placental malaria. J Biol Chem (2008) 1.58
HIV impairs opsonic phagocytic clearance of pregnancy-associated malaria parasites. PLoS Med (2007) 1.49
Structural comparison of two CSPG-binding DBL domains from the VAR2CSA protein important in malaria during pregnancy. J Mol Biol (2009) 1.36
Antigenic differences and conservation among placental Plasmodium falciparum-infected erythrocytes and acquisition of variant-specific and cross-reactive antibodies. J Infect Dis (2006) 1.34
The role of Plasmodium falciparum var genes in malaria in pregnancy. Mol Microbiol (2004) 1.24
Plasmodium falciparum-infected erythrocytes adhere both in the intervillous space and on the villous surface of human placenta by binding to the low-sulfated chondroitin sulfate proteoglycan receptor. Am J Pathol (2004) 1.19
Immunization with VAR2CSA-DBL5 recombinant protein elicits broadly cross-reactive antibodies to placental Plasmodium falciparum-infected erythrocytes. Infect Immun (2010) 1.18
Evaluation of the antigenic diversity of placenta-binding Plasmodium falciparum variants and the antibody repertoire among pregnant women. Infect Immun (2010) 1.15
High levels of antibodies to multiple domains and strains of VAR2CSA correlate with the absence of placental malaria in Cameroonian women living in an area of high Plasmodium falciparum transmission. Infect Immun (2012) 1.15
Expression of variant surface antigens by Plasmodium falciparum parasites in the peripheral blood of clinically immune pregnant women indicates ongoing placental infection. Infect Immun (2003) 1.11
High avidity antibodies to full-length VAR2CSA correlate with absence of placental malaria. PLoS One (2012) 1.09
Effects of pregnancy and intensity of Plasmodium falciparum transmission on immunoglobulin G subclass responses to variant surface antigens. Infect Immun (2005) 1.07
Immunohistological characterization of macrophage migration inhibitory factor expression in Plasmodium falciparum-infected placentas. Infect Immun (2005) 1.07
Recrudescent Plasmodium berghei from pregnant mice displays enhanced binding to the placenta and induces protection in multigravida. PLoS One (2009) 1.00
Malaria in pregnant women in an area with sustained high coverage of insecticide-treated bed nets. Malar J (2008) 0.98
Protective Antibodies against Placental Malaria and Poor Outcomes during Pregnancy, Benin. Emerg Infect Dis (2015) 0.96
Clinical malaria among pregnant women on combined insecticide treated nets (ITNs) and intermittent preventive treatment (IPTp) with sulphadoxine-pyrimethamine in Yaounde, Cameroon. BMC Womens Health (2014) 0.94
Parity and placental infection affect antibody responses against Plasmodium falciparum during pregnancy. Infect Immun (2011) 0.93
Rapid acquisition of isolate-specific antibodies to chondroitin sulfate A-adherent plasmodium falciparum isolates in Ghanaian primigravidae. Infect Immun (2005) 0.93
Developmental stage- and cell cycle number-dependent changes in characteristics of Plasmodium falciparum-infected erythrocyte adherence to placental chondroitin-4-sulfate proteoglycan. Infect Immun (2007) 0.92
HIV and co-infections. Immunol Rev (2013) 0.92
The antibody response of pregnant Cameroonian women to VAR2CSA ID1-ID2a, a small recombinant protein containing the CSA-binding site. PLoS One (2014) 0.92
Malaria evolution in South Asia: knowledge for control and elimination. Acta Trop (2012) 0.91
Kinetics of B cell responses to Plasmodium falciparum erythrocyte membrane protein 1 in Ghanaian women naturally exposed to malaria parasites. J Immunol (2014) 0.91
Chondroitin sulfate proteoglycan expression and binding of Plasmodium falciparum-infected erythrocytes in the human placenta during pregnancy. Infect Immun (2003) 0.91
A model of parity-dependent immunity to placental malaria. Nat Commun (2013) 0.90
Overproduction, purification and crystallization of a chondroitin sulfate A-binding DBL domain from a Plasmodium falciparum var2csa-encoded PfEMP1 protein. Acta Crystallogr Sect F Struct Biol Cryst Commun (2008) 0.88
Analysis of IgG with specificity for variant surface antigens expressed by placental Plasmodium falciparum isolates. Malar J (2004) 0.86
Advances and challenges in malaria vaccine development. Expert Rev Mol Med (2009) 0.86
Towards the rational design of a candidate vaccine against pregnancy associated malaria: conserved sequences of the DBL6epsilon domain of VAR2CSA. PLoS One (2010) 0.85
Comparison of the specificity of antibodies to VAR2CSA in Cameroonian multigravidae with and without placental malaria: a retrospective case-control study. Malar J (2015) 0.83
Immune selection and within-host competition can structure the repertoire of variant surface antigens in Plasmodium falciparum--a mathematical model. PLoS One (2010) 0.83
Antibodies that inhibit binding of Plasmodium falciparum-infected erythrocytes to chondroitin sulfate A and to the C terminus of merozoite surface protein 1 correlate with reduced placental malaria in Cameroonian women. Infect Immun (2004) 0.83
B-cell responses to pregnancy-restricted and -unrestricted Plasmodium falciparum erythrocyte membrane protein 1 antigens in Ghanaian women naturally exposed to malaria parasites. Infect Immun (2014) 0.82
Prospects and Pitfalls of Pregnancy-Associated Malaria Vaccination Based on the Natural Immune Response to Plasmodium falciparum VAR2CSA-Expressing Parasites. Malar Res Treat (2012) 0.81
Plasmodium falciparum infection significantly impairs placental cytokine profile in HIV infected Cameroonian women. PLoS One (2009) 0.81
IFN-gamma and TNF associated with severe falciparum malaria infection in Saudi pregnant women. Malar J (2014) 0.80
Influence of Intermittent Preventive Treatment on Antibodies to VAR2CSA in Pregnant Cameroonian Women. Am J Trop Med Hyg (2015) 0.79
How specific is Plasmodium falciparum adherence to chondroitin 4-sulfate? Trends Parasitol (2011) 0.78
The impact of IgG antibodies to recombinant Plasmodium falciparum 732var CIDR-1alpha domain in mothers and their newborn babies. Parasitol Res (2007) 0.77
VAR2CSA Domain-Specific Analysis of Naturally Acquired Functional Antibodies to Plasmodium falciparum Placental Malaria. J Infect Dis (2016) 0.76
Epidemiology and Risk Analysis of Malaria among Pregnant Women. Iran J Public Health (2012) 0.76
Identification of a Major Dimorphic Region in the Functionally Critical N-Terminal ID1 Domain of VAR2CSA. PLoS One (2015) 0.76
Association between malaria immunity and pregnancy outcomes among Malawian pregnant women receiving nutrient supplementation. Malar J (2016) 0.75
Provider and user acceptability of intermittent screening and treatment for the control of malaria in pregnancy in Malawi. Malar J (2016) 0.75
Antibody responses to the full-length VAR2CSA and its DBL domains in Cameroonian children and teenagers. Malar J (2016) 0.75
Resisting and tolerating P. falciparum in pregnancy under different malaria transmission intensities. BMC Med (2017) 0.75
Multiplexing detection of IgG against Plasmodium falciparum pregnancy-specific antigens. PLoS One (2017) 0.75
Statistical prediction of immunity to placental malaria based on multi-assay antibody data for malarial antigens. Malar J (2017) 0.75
Synchronization of Plasmodium falciparum erythrocytic stages in culture. J Parasitol (1979) 23.90
Adherence of Plasmodium falciparum to chondroitin sulfate A in the human placenta. Science (1996) 10.03
Human cerebral malaria. A quantitative ultrastructural analysis of parasitized erythrocyte sequestration. Am J Pathol (1985) 7.14
An analysis of malaria in pregnancy in Africa. Bull World Health Organ (1983) 6.09
Maternal antibodies block malaria. Nature (1998) 5.67
Malaria pathogenesis. Science (1994) 4.76
The impact of placental malaria on gestational age and birth weight. J Infect Dis (2000) 4.25
Concentration from continuous culture of erythrocytes infected with trophozoites and schizonts of Plasmodium falciparum. Am J Trop Med Hyg (1978) 3.46
Malaria during pregnancy: a priority area of malaria research and control. Parasitol Today (1995) 3.42
Host age as a determinant of naturally acquired immunity to Plasmodium falciparum. Parasitol Today (1995) 3.00
Placental pathology in malaria: a histological, immunohistochemical, and quantitative study. Hum Pathol (2000) 2.84
Malaria elicits type 1 cytokines in the human placenta: IFN-gamma and TNF-alpha associated with pregnancy outcomes. J Immunol (1998) 2.80
Microvascular sequestration of parasitized erythrocytes in human falciparum malaria: a pathological study. Am J Trop Med Hyg (1991) 2.76
Placental malaria is associated with cell-mediated inflammatory responses with selective absence of natural killer cells. J Infect Dis (2001) 1.84
PfEMP1, polymorphism and pathogenesis. Ann Trop Med Parasitol (1997) 1.56
Structural requirements for the adherence of Plasmodium falciparum-infected erythrocytes to chondroitin sulfate proteoglycans of human placenta. J Biol Chem (2000) 1.55
Malaria, the red cell, and the endothelium. Annu Rev Med (1994) 1.48
Maternal malaria and parasite adhesion. J Mol Med (Berl) (1998) 1.46
Development of antibodies against chondroitin sulfate A-adherent Plasmodium falciparum in pregnant women. Infect Immun (1999) 1.41
Chondroitin-4-sulfate impairs in vitro and in vivo cytoadherence of Plasmodium falciparum infected erythrocytes. Mol Med (1997) 1.39
Ex vivo desequestration of Plasmodium falciparum-infected erythrocytes from human placenta by chondroitin sulfate A. Infect Immun (1999) 1.29
Biological and biochemical characteristics of cytoadhesion of Plasmodium falciparum-infected erythrocytes to chondroitin-4-sulfate. Infect Immun (1998) 1.18
Chondroitin sulphate A as an adherence receptor for Plasmodium falciparum-infected erythrocytes. Parasitol Today (1997) 1.13
Cytoadherence of Plasmodium falciparum-infected erythrocytes in the human placenta. Parasite Immunol (2000) 1.05
Amplification of cytoadherence in cerebral malaria: towards a more rational explanation of disease pathophysiology. Ann Trop Med Parasitol (1993) 1.02
Motherhood and malaria. Nat Med (1998) 0.89
Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med (1991) 18.33
Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc Natl Acad Sci U S A (1998) 13.39
Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med (1998) 11.27
Increased absenteeism from work after detection and labeling of hypertensive patients. N Engl J Med (1978) 9.29
The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure. Can Med Assoc J (1985) 8.06
Randomised clinical trial of strategies for improving medication compliance in primary hypertension. Lancet (1975) 7.22
Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis. Lancet (2003) 5.90
Bacterial cell division protein FtsZ assembles into protofilament sheets and minirings, structural homologs of tubulin polymers. Proc Natl Acad Sci U S A (1996) 5.51
Improvement of medication compliance in uncontrolled hypertension. Lancet (1976) 4.84
Live attenuated malaria vaccine designed to protect through hepatic CD8⁺ T cell immunity. Science (2011) 4.72
Determining optimal therapy--randomized trials in individual patients. N Engl J Med (1986) 4.49
Effect of encouragement on walking test performance. Thorax (1984) 4.44
Secretion of a malarial histidine-rich protein (Pf HRP II) from Plasmodium falciparum-infected erythrocytes. J Cell Biol (1986) 3.51
The North American Symptomatic Carotid Endarterectomy Trial : surgical results in 1415 patients. Stroke (1999) 3.31
Can simple clinical measurements detect patient noncompliance? Hypertension (1981) 3.29
Does a mailed continuing education program improve physician performance? Results of a randomized trial in antihypertensive care. JAMA (1986) 3.04
A randomized trial of a family physician intervention for smoking cessation. JAMA (1988) 3.03
Do the facts and figures warrant a 10-fold increase in the performance of carotid endarterectomy on asymptomatic patients? Neurology (1996) 2.89
The manuscript lecture-notes of Alexander Monro, secundus (1733-1817). Med Hist (1978) 2.70
Efficacy of recombinant circumsporozoite protein vaccine regimens against experimental Plasmodium falciparum malaria. J Infect Dis (2001) 2.54
Identification of Plasmodium falciparum histidine-rich protein 2 in the plasma of humans with malaria. J Clin Microbiol (1991) 2.49
Comparative analysis of the Plasmodium falciparum histidine-rich proteins HRP-I, HRP-II and HRP-III in malaria parasites of diverse origin. Parasitology (1987) 2.45
Defective prohormone processing and altered pancreatic islet morphology in mice lacking active SPC2. Proc Natl Acad Sci U S A (1997) 2.42
A dominant negative mutant of 2-5A-dependent RNase suppresses antiproliferative and antiviral effects of interferon. EMBO J (1993) 2.28
Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria Vaccine. N Engl J Med (2015) 2.18
Should study subjects see their previous responses? J Chronic Dis (1985) 2.17
Detection of the Plasmodium falciparum antigen histidine-rich protein 2 in blood of pregnant women: implications for diagnosing placental malaria. J Clin Microbiol (1999) 2.16
Acquisition and decay of antibodies to pregnancy-associated variant antigens on the surface of Plasmodium falciparum-infected erythrocytes that protect against placental parasitemia. J Infect Dis (2001) 2.15
Single-patient randomised clinical trial. Use in determining optimum treatment for patient with inflammation of Kock continent ileostomy reservoir. Lancet (1986) 2.06
Membrane glycoprotein CD36: a review of its roles in adherence, signal transduction, and transfusion medicine. Blood (1992) 2.06
Long-term efficacy and immune responses following immunization with the RTS,S malaria vaccine. J Infect Dis (1998) 2.00
Induction of crisis forms in the human malaria parasite Plasmodium falciparum by gamma-interferon-activated, monocyte-derived macrophages. J Immunol (1984) 1.95
Monoclonal antibody OKM5 inhibits the in vitro binding of Plasmodium falciparum-infected erythrocytes to monocytes, endothelial, and C32 melanoma cells. J Immunol (1985) 1.92
Malaria rapid diagnostic devices: performance characteristics of the ParaSight F device determined in a multisite field study. J Clin Microbiol (2001) 1.90
Glycosylphosphatidylinositol anchors of Plasmodium falciparum: molecular characterization and naturally elicited antibody response that may provide immunity to malaria pathogenesis. J Exp Med (2000) 1.87
Bronchodilators in chronic air-flow limitation. Effects on airway function, exercise capacity, and quality of life. Am Rev Respir Dis (1987) 1.85
Activation of p38 mitogen-activated protein kinase and c-Jun NH(2)-terminal kinase by double-stranded RNA and encephalomyocarditis virus: involvement of RNase L, protein kinase R, and alternative pathways. Mol Cell Biol (2000) 1.83
An aptian plant with attached leaves and flowers: implications for angiosperm origin. Science (1990) 1.82
Labelling in hypertension: a review of the behavioural and psychological consequences. J Chronic Dis (1984) 1.75
Educational package on hypertension for primary care physicians. Can Med Assoc J (1984) 1.73
Canadian Hemodialysis Morbidity Study. Am J Kidney Dis (1992) 1.72
Intrinsic molecular activities of the interferon-induced 2-5A-dependent RNase. J Biol Chem (1994) 1.67
Organization of NMDA receptors at extrasynaptic locations. Neuroscience (2010) 1.66
Clinical trial of common treatments for low back pain in family practice. Br Med J (Clin Res Ed) (1985) 1.58
Oxidative killing of the intraerythrocytic malaria parasite Plasmodium yoelii by activated macrophages. J Immunol (1984) 1.57
Understanding Canadian student motivations and beliefs about giving blood. Transfusion (2005) 1.55
Structural requirements for the adherence of Plasmodium falciparum-infected erythrocytes to chondroitin sulfate proteoglycans of human placenta. J Biol Chem (2000) 1.55
Apo2L/TRAIL and Bcl-2-related proteins regulate type I interferon-induced apoptosis in multiple myeloma. Blood (2001) 1.54
Measurement of quality of life in end-stage renal disease: the time trade-off approach. Clin Invest Med (1987) 1.53
Cyclophosphamide and plasma exchange in multiple sclerosis. Lancet (1991) 1.50
Vaccination of experimental monkeys against Plasmodium falciparum: a possible safe adjuvant. Science (1978) 1.49
Further evidence relating mitral-valve prolapse to cerebral ischemic events. N Engl J Med (1980) 1.48
Self-recording of blood pressure in the management of hypertension. Can Med Assoc J (1978) 1.46
Severe defect in proglucagon processing in islet A-cells of prohormone convertase 2 null mice. J Biol Chem (2001) 1.45
Patients' perspectives of a physician-delivered smoking cessation intervention. Am J Prev Med (1991) 1.45
Internal carotid occlusion: a prospective study. Stroke (1984) 1.42
Absence of cellular responses to a putative autoantigen in onchocercal chorioretinopathy. Cellular autoimmunity in onchocercal chorioretinopathy. Invest Ophthalmol Vis Sci (1996) 1.42
Report of a consultation on the optimization of clinical challenge trials for evaluation of candidate blood stage malaria vaccines, 18-19 March 2009, Bethesda, MD, USA. Vaccine (2009) 1.41
The manuscript lecture-notes of Alexander Monro primus (1697-1767). Med Hist (1986) 1.40
Are the results of the extracranial-intracranial bypass trial generalizable? N Engl J Med (1987) 1.39
Antibodies to a histidine-rich protein (PfHRP1) disrupt spontaneously formed Plasmodium falciparum erythrocyte rosettes. Proc Natl Acad Sci U S A (1990) 1.34
Sequence and expression of a major egg antigen from Schistosoma mansoni. Homologies to heat shock proteins and alpha-crystallins. Mol Biochem Parasitol (1986) 1.33
The three-dimensional structure of alpha-actinin obtained by cryoelectron microscopy suggests a model for Ca(2+)-dependent actin binding. J Mol Biol (2001) 1.33
Patient compliance with antihypertensive regimens. Patient Couns Health Educ (1978) 1.31
Formation of 2-D paracrystals of F-actin on phospholipid layers mixed with quaternary ammonium surfactants. J Struct Biol (1993) 1.30
Immunoprecipitation of surface antigen precursors from Schistosoma mansoni messenger RNA in vitro translation products. Mol Biochem Parasitol (1984) 1.30
Antimalarial antibodies of the immunoglobulin G2a isotype modulate parasitemias in mice infected with Plasmodium yoelii. Infect Immun (1991) 1.29
The epidemiology of Plasmodium falciparum malaria in two Cameroonian villages: Simbok and Etoa. Am J Trop Med Hyg (2001) 1.28
Molecular pathology of X linked retinoschisis: mutations interfere with retinoschisin secretion and oligomerisation. Br J Ophthalmol (2006) 1.28
Manipulation of the therapeutic regimen to improve compliance: conceptions and misconceptions. Clin Pharmacol Ther (1977) 1.25
Purification and partial characterization of an unusual protein of Plasmodium falciparum: histidine-rich protein II. Mol Biochem Parasitol (1989) 1.23
Compliance with antihypertensive drug therapy. Ann N Y Acad Sci (1978) 1.23
RNase L-independent specific 28S rRNA cleavage in murine coronavirus-infected cells. J Virol (2000) 1.22
Effects on capacitance by overexpression of membrane proteins. Biochem Biophys Res Commun (2008) 1.22
Formation of two-dimensional complexes of F-actin and crosslinking proteins on lipid monolayers: demonstration of unipolar alpha-actinin-F-actin crosslinking. Biophys J (1994) 1.20
Effects of pregnancy on inulin and para-aminohippurate clearances in the anaesthetized rat. J Physiol (1960) 1.20
Analysis of human T cell clones specific for conserved peptide sequences within malaria proteins. Paucity of clones responsive to intact parasites. J Immunol (1994) 1.20
Targeting RNA for degradation with a (2'-5')oligoadenylate-antisense chimera. Proc Natl Acad Sci U S A (1993) 1.19
Evaluation of a rapid test for histidine rich protein 2 for diagnosis of Plasmodium falciparum infection in Cameroonian children. Trans R Soc Trop Med Hyg (1999) 1.19
The vaccinia virus A18R DNA helicase is a postreplicative negative transcription elongation factor. J Virol (1998) 1.15
Hydrophobicity scale for proteins based on inverse temperature transitions. Biopolymers (1992) 1.15
Toxoplasmosis in immunoglobulin M-suppressed mice. Infect Immun (1982) 1.15
Effects of labelling on income, work and social function among hypertensive employees. J Chronic Dis (1984) 1.13
Effect of deficiency of the double-stranded RNA-dependent protein kinase, PKR, on antiviral resistance in the presence or absence of ribonuclease L: HSV-1 replication is particularly sensitive to deficiency of the major IFN-mediated enzymes. J Interferon Cytokine Res (2000) 1.13
Amino acid sequence of the center of the arginine-lysine-rich histone from calf thymus. The total sequence. J Biol Chem (1972) 1.12
The neuroendocrine protein 7B2 is required for peptide hormone processing in vivo and provides a novel mechanism for pituitary Cushing's disease. Cell (1999) 1.12
Racial differences in the anterior circulation in cerebrovascular disease. How much can be explained by risk factors? Arch Neurol (1990) 1.12
Functional status changes following medical or surgical treatment for cerebral ischemia. Results of the extracranial-intracranial bypass study. JAMA (1987) 1.12